Recall Record

Danvers, MA, United States

Abiomed, Inc. recalls

31 recalls recorded since 2018, most recently on 12 August 2026. 27 are listed as ongoing. Status and classification are as published by the FDA.

Recalls31
Ongoing (FDA)27
Terminated or completed4
Class I (FDA)21

Ongoing Class I Medical devices

Recall started
12 August 2026
Reason
The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.
Distribution
Domestic: Nationwide Distribution. International: United Arab Emirates, Austria, Australia, Belgium, Brunei Darussalam, Brazil, Canada, Switzerland, Chile, China, Colombia, Costa Rica, Cyprus, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Croatia, Hungary, Ir
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3148-2026, Z-3149-2026, Z-3150-2026

Ongoing Class I Medical devices

Recall started
11 June 2026
Reason
A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.
Distribution
Worldwide distribution. US Nationwide, Australia (AU), Austria (AT), Belgium (BE), Brazil (BR), Brunei (BN), Canada (CA), China (CN), Croatia (HR), Czech Republic (CZ), Denmark (DK), Finland (FI), France (FR), Germany (DE), Greece (GR), Hong Kong (HK), Ireland (IE), Israel (IL), Italy (IT), Japan (
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2682-2026, Z-2685-2026, Z-2683-2026, Z-2692-2026, Z-2689-2026, Z-2686-2026, Z-2688-2026, Z-2681-2026, Z-2691-2026, Z-2687-2026, Z-2693-2026, Z-2690-2026 and 1 more

Ongoing Class I Medical devices

Recall started
22 May 2026
Reason
Potential for thrombus formation during prolonged use of the introducer.
Distribution
Worldwide - US Nationwide distribution in the states of FL, IL, MN, NJ, NY, VA and the country of Japan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2601-2026, Z-2600-2026, Z-2599-2026, Z-2602-2026

Ongoing Class I Medical devices

Recall started
18 May 2026
Reason
Exposure to the low purge pressure occurrence may result in persistent low purge pressure alarms and, in some cases, interruption or loss of mechanical circulatory support.
Distribution
US distribution to GA, IA, NE, PA, TX, WA, WI. International distribution to Czech Republic, Norway, and Japan
Initiated
Voluntary: Firm initiated
Recall number
Z-2457-2026

Ongoing Class I Medical devices

Recall started
14 May 2026
Reason
Potential software error in the Automated Impella Controller ("AIC" ) when used in conjunction with left ventricular Impella devices.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Brunei, Canada, China, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand,
Initiated
Voluntary: Firm initiated
Recall number
Z-2360-2026

Ongoing Class I Medical devices

Recall started
20 April 2026
Reason
A retrospective review identified that there are AIC units requiring specific hardware updates to address potential safety concerns. These hardware updates have been implemented through Abiomed s servicing process; therefore, AICs that have not received service are pending these updates. Issue 1: The proximity of the internal Video Graphics Array cable to the Digital Signal Processor chipset on the Impellatronic printed circuit assembly could potentially result in Electrostatic Discharge coupling into the Digital Signal Processor which may interrupt motor controls. Issue 2: There is a potential for the Compact Flash Memory Card dislodgement due to external applied forces, which could result in AIC startup failures and data logging issues. Issue 3: Improper routing of the fan wire within the AIC could lead to fan wire damage, which may result in console boot-up failure. Issue 4: Potential capacitor related issues on the Power Battery Manager, including the potential for the capacitors to cause pump stop, purge stop, and/or single fan fuse failures.
Distribution
Worldwide - US Nationwide distribution in the states of CA, CT, FL, LA, MA, MI, MO, MS, ND, NY, OH, PA, TX, WY and the countries of Brazil, Canada, Colombia, Hong Kong, Italy, Kuwait, Saudi Arabia, UAE, United Kingdom;
Initiated
Voluntary: Firm initiated
Recall number
Z-2211-2026

Ongoing Class I Medical devices

Recall started
18 February 2026
Reason
Increased risk of purge leaks with Generation 1 purge cassettes.
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1589-2026

Ongoing Class I Medical devices

Recall started
16 February 2026
Reason
Potential that the "Purge System Blocked" alarm display on the Automated Impella Controller (AIC) could be delayed when using first generation Impella 5.5 (0550-0008*) pumps.
Distribution
International distribution in the country of Australia, Canada, France, Germany, Kuwait.
Initiated
Voluntary: Firm initiated
Recall number
Z-1591-2026

Ongoing Class I Medical devices

Recall started
27 January 2026
Reason
Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.
Distribution
Worldwide distribution - US Nationwide and the countries of Austria, Canada, Croatia, Czechia, France, Germany, Hong Kong, Italy, Poland, Serbia, Switzerland.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1470-2026, Z-1469-2026, Z-1471-2026

Ongoing Class II Medical devices

Recall started
4 December 2025
Reason
Device packaged in incorrect outer box carton.
Distribution
International distribution to the country of Australia and Taiwan.
Initiated
Voluntary: Firm initiated
Recall number
Z-1030-2026

Ongoing Class I Medical devices

Recall started
1 October 2025
Reason
Potential cybersecurity vulnerabilities related to the operating system in the Automated Impella Controller (AIC).
Distribution
Nationwide distribution. International distribution to United Arab Emirates, Austria, Australia, Belgium, Brunei Darussalam, Brazil, Canada, Switzerland, Colombia, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom of Great Britain and Northern Ireland, Greece, Hong Kong, Croatia, Ire
Initiated
Voluntary: Firm initiated
Recall number
Z-0069-2026

Ongoing Class I Medical devices

Recall started
16 September 2025
Reason
Potential for Automated Impella Controller (AIC) purge pressure issues due to purge retainer failures.
Distribution
Worldwide distribution. US Nationwide, Australia, Austria, Belgium, Brazil, Canada, Columbia, Croatia, Czechia, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Isreal, Italy, Japan, Kuwait, Luxembourg, Mexico, Netherlands, Pakistan, Panama, Poland, Saudi Arabia, Singapore, Spain, Sweden
Initiated
Voluntary: Firm initiated
Recall number
Z-0136-2026

Ongoing Class I Medical devices

Recall started
20 August 2025
Reason
Specific Automated Impella Controllers (AICs) that have a Pump Driver Circuit Assembly do not meet current specifications. This may lead to decreased pump performance or pump stop and trigger an Impella Failure or Impella Stopped Controller Failure alarm.
Distribution
US distribution to AR, AZ, CA, CO, CT, FL, GA, ID, MA, MI, MO, MS, NJ, NY, OH, PA, TX. International distribution to Canada, Germany, Great Britian, Italy, Netherlands, Norway.
Initiated
Voluntary: Firm initiated
Recall number
Z-2568-2025

Ongoing Class I Medical devices

Recall started
23 June 2025
Reason
A potential issue with the Automated Impella Controller (AIC) not detecting an Impella pump when it is connected
Distribution
Worldwide distribution. US Nationwide, Australia, Austria, Belgium, Brunei Darussalam, Canada, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Pakistan, Panama, Poland,
Initiated
Voluntary: Firm initiated
Recall number
Z-2164-2025

Ongoing Class I Medical devices

Recall started
12 December 2024
Reason
Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing that there is a risk of potential interaction between the tip of guidewires, indwelling central venous lines or devices and inlet of the Impella pumps listed above during the insertion, manipulation, and removal of those devices. The interaction may result in optical sensor damage, temporary pump stop, or permanent pump stop.
Distribution
Domestic: Nationwide Distribution International: Canada
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0830-2025, Z-0829-2025

Ongoing Class II Medical devices

Recall started
5 August 2024
Reason
A potential device interaction between the Shockwave Coronary IVL Catheter and left-sided Impella Pumps during coronary interventions. Currently there is no Abiomed labeling (IFU etc.) content related to this potential interaction, so Abiomed will update the IFU to include information on this potential device interaction.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Brunei Darussalam, Canada, Croatia, Czeck Republic, Denmark, Finland, France, Germany, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Panama,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2967-2024, Z-2957-2024, Z-2966-2024, Z-2964-2024, Z-2961-2024, Z-2960-2024, Z-2969-2024, Z-2970-2024, Z-2965-2024, Z-2955-2024, Z-2958-2024, Z-2971-2024 and 6 more

Ongoing Class I Medical devices

Recall started
31 May 2024
Reason
Nine (9) Impella CP pumps failed inspection and were inadvertently released.
Distribution
Domestic only: FL, MA, OH TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-2319-2024

Ongoing Class II Medical devices

Recall started
27 December 2023
Reason
New warnings are being added to the Instructions for Use for all affected products to reduce the possibility of fibers being drawn into the Impella, which may result in low flow of the device.
Distribution
Worldwide distribution - US Nationwide and the countries of AU, CA, DE, FR, IN, MX, TW, and VI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1074-2024

Ongoing Class I Medical devices

Recall started
27 December 2023
Reason
IFU has been updated to include warnings about the risk of the inlet perforating through the myocardial wall of the left ventricle due to operator handling.
Distribution
Worldwide distribution - US Nationwide and the countries of AU, CA, DE, FR, IN, MX, TW, and VI.
Initiated
Voluntary: Firm initiated
Recall number
Z-0980-2024

Ongoing Class II Medical devices

Recall started
6 December 2023
Reason
The following features have been disabled from the web-based portal because the FDA has not evaluated these features for safety and effectiveness: Notifications via email feature; AIC alarm color on case tile feature; Sort case tiles by AIC alarm color feature; Pump metric display on case tile feature
Distribution
Domestic distribution nationwide.
Initiated
Voluntary: Firm initiated
Recall number
Z-0636-2024

Ongoing Class II Medical devices

Recall started
7 November 2023
Reason
Hole(s) to the outer pouch of the Introducer Kits (both trayed and non-trayed) may compromise the sterile barrier of the Introducer Kits. Non-sterile product exposes patients to the possibility of the introduction of micro-organisms into the vasculature and/or access site, leading to an infectious process, bacteremia or sepsis
Distribution
Nationwide Foreign: Country AT AU BE BR CA CA CH CZ DE DK ES FR FR HK IN IT MX MY NL NO PA SG TW UK
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0652-2024, Z-0653-2024, Z-0646-2024, Z-0651-2024, Z-0648-2024, Z-0650-2024, Z-0647-2024, Z-0655-2024, Z-0649-2024, Z-0654-2024

Terminated Class II Medical devices

Recall started
10 October 2023
Terminated
6 March 2025
Reason
Pump not detected as connected to controller due to software issue.
Distribution
US: AZ, CA, FL, NY & VA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0441-2024, Z-0440-2024

Ongoing Class I Medical devices

Recall started
29 June 2023
Reason
A higher than expected rate of thrombus formation or deposition has been observed. The risk is for thrombus formations or deposits on indwelling central venous lines or cannulas may break free and enter into the Impella RP Flex, resulting in reduced flow, loss of support, or hemolysis
Distribution
US Nationwide distribution including in the states of AR, CA, FL, GA, LA, MA, MI, MO, NC, NJ, NY, OH, OR, SC, TX, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-2281-2023

Ongoing Class I Medical devices

Recall started
14 June 2023
Reason
There is a potential risk for unintentional interaction of the Impella motor housing with the distal stent of a transcatheter aortic valve replacement (TAVR) resulting in destruction of the impeller blades. This has resulted in low flow from the damaged Impella system. Systemic embolization of the fractured impeller material is a possibility.
Distribution
Worldwide distribution - US Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2113-2023, Z-2112-2023, Z-2116-2023, Z-2111-2023, Z-2115-2023, Z-2114-2023

Ongoing Class II Medical devices

Recall started
26 May 2023
Reason
There was one complaint that the sidearm of the device detached during explant of a pump. When the sidearms are subjected to heat, humidity and articulation, a silicone oil contaminant that was unintentionally introduced during manufacturing at the joint between the sidearm and the hub may cause the joint to detach.
Distribution
US Nationwide distribution in the states of MN, NJ, TN.
Initiated
Voluntary: Firm initiated
Recall number
Z-2128-2023

Ongoing Class I Medical devices

Recall started
17 April 2023
Reason
The Impella 5.5 pump experienced a heightened complaint rate for purge leaks.
Distribution
US Nationwide. Japan, Saudi Arabia, Kuwait, Italy, Spain, Switzerland, Austria, France, Great Britain, Croatia, Serbia, Norway, Slovenia, Germany
Initiated
Voluntary: Firm initiated
Recall number
Z-1590-2023

Terminated Class I Medical devices

Recall started
14 December 2021
Terminated
28 February 2023
Reason
The firm has received complaints of the OXY-1 System Console experiencing a power interruption while in use, which disrupts therapy delivered to a patient on support. Disruption of therapy could lead to prolonged hypoxia.
Distribution
US distribution to FL, GA, IN, MD, NC, PA, TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-0550-2022

Terminated Class II Medical devices

Recall started
1 March 2021
Terminated
6 March 2025
Reason
Retrospective reporting for the release of Technical Bulletin IMP-2643 AIC Version 8.5 Software Update Available. The update resolved an issue in version 8.4 where a pump was not recognized by the AIC.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1175-2024

Terminated Class II Medical devices

Recall started
4 September 2019
Terminated
21 January 2020
Reason
This one pump shipped with incorrect pump programming, the initial production working version of the program. The pump would have immediately run at P9 for all selected P-levels, rather than a 10 second ramp up period. The pump may have migrated out of position and possibly caused injury. The positioning and suction alarms were also disabled.
Distribution
The product was distributed to GA
Initiated
Voluntary: Firm initiated
Recall number
Z-0345-2020

Ongoing Class II Medical devices

Recall started
19 February 2019
Reason
Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system performance depends on. 2. Software defects leading to unreliable or missing placement signal, unresponsive start Impella soft key during disconnect/reconnect, and false Position in Ventricle alarm in certain AICs.
Distribution
Worldwide - US Nationwide and the countries of Austria, Belgium, Canada, France, Germany, Hong Kong, Italy, Luxembourg, Poland, Spain, Switzerland, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-3251-2026

Ongoing Class I Medical devices

Recall started
17 January 2011
Reason
Retrospective submission for following issues identified: 1. Alarm failures, power-path faults, electrical-short risks, and inaccurate motor-current sensing were identified in certain AIC consoles. 2. There is improper alignment between the purge cassette and the motor drive in the AIC. This can result in a piston block event and lead to the inability to complete priming of the purge system, requiring the user to switch to backup AIC console.
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, Denmark, France, Germany, Italy, Kuwait, Netherlands, Norway, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall number
Z-2238-2026

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.